10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
89Bio Inc. (ETNB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 14,175,398 | $110,851,612 | 1.47% | |
| 2. | Suvretta Capital Management Aaron Cowen | 10,202,696 | $79,785,083 | +28% | 2.71% |
| 3. | Deep Track Capital David Kroin | 6,478,249 | $50,659,907 | +135% | 1.88% |
| 4. | Citadel Investment Group Ken Griffin | 4,729,852 | $36,987,443 | +85% | 0% |
| 5. | Biotechnology Value Fund / BVF Inc Mark Lampert | 4,333,885 | $33,890,981 | -37% | 1.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.75 | 5,714,285 | 19,554,319 | 2025-01-30 | Filing | ||
| $6.71 | 10,000 | 25,000 | 2025-01-22 | Filing | ||
| $6.55 | 5,000 | 15,000 | 2025-01-21 | Filing | ||
| $7.89 | 5,000 | 471,236 | 2024-12-06 | Filing | ||
| $8.00 | 10,000 | 10,000 | 2024-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.49 | 10,963 | 271,833 | 2025-01-15 | Filing | ||
| $8.12 | 27,955 | 187,796 | 2024-10-30 | Filing | ||
| $10.91 | 52,718 | 459,171 | 2024-04-01 | Filing | ||
| $10.76 | 4,477 | 486,889 | 2024-02-26 | Filing | ||
| $11.20 | 50,000 | 301,225 | 2023-12-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,514,056 | $129,177,176 | 0.06% | |
| 2. | 7,890,099 | $61,700,575 | 0% | |
| 3. | 7,478,061 | $58,478,437 | 0.88% | |
| 4. | 5,692,331 | $44,514,028 | 0% | |
| 5. | 3,886,794 | $30,394,729 | 0.13% |
News See All
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
5 Stocks Insiders are Buying Now
Satellite communication and internet services company EchoStar Corp (NASDAQ:SATS) ranks fifth in our list of the stocks with the highest insider purchasing activity recently.
11 Best Small-Cap Growth Stocks to Invest In
In this piece, we will take a look at the 11 best small-cap growth stocks to invest in.
15 Most Shorted Stocks That Are Loved By Analysts
In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts.
Analysts Are Increasing Price Targets of These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target hike from analysts.
Hedge Fund and Insider Trading News: Hestia Capital Management, Tiger Global Management, Rockefeller Capital Management, Farallon Capital Management, Odey Asset Management, Rokos Capital Management, Excalibur Fixed Income Fund, Xos Inc (XOS), 89bio, Inc. (ETNB), and More
Tiger Global Management founder Chase Coleman, whose firm was stung by last year’s tech rout, said the sector now looks attractive thanks to artificial intelligence and other new technologies.
Hedge Fund and Insider Trading News: Sachem Head Capital Management, Bridgewater Associates, AQR Capital Management, CABA Capital, 89bio Inc (ETNB), Southwest Gas Holdings, Inc. (SWX), and More
Sachem Head Capital Management has amassed a stake in Arconic Corp (ARNC.N) and has been pushing the U.S.
12 Best Biotech Stocks To Buy Under $20
The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was this industry that developed messenger ribonucleic acid (mRNA...
Hedge Fund and Insider Trading News: Ray Dalio, Citadel, Brevan Howard Asset Management, PriorNilsson Fonder, Nordic Capital, Union Pacific Corporation (UNP), 89bio Inc (ETNB), and More
NEW YORK (AP) — An “unauthorized, unvarnished” biography of billionaire hedge-fund manager Ray Dalio will be published next fall, authored by a Wall Street Journal investigative reporter whom the...
Billionaire Hedge Funds
